Emerging Gene Therapy Approaches in the Management of Spinal Muscular Atrophy (SMA): An Overview of Clinical Trials and Patent Landscape.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
06 Sep 2023
Historique:
received: 30 06 2023
revised: 28 08 2023
accepted: 29 08 2023
medline: 29 9 2023
pubmed: 28 9 2023
entrez: 28 9 2023
Statut: epublish

Résumé

Spinal muscular atrophy (SMA) is a rare autosomal recessive neuromuscular disease that is characterized by progressive muscle atrophy (degeneration), including skeletal muscles in charge of the ability to move. SMA is caused by defects in the SMN1 gene (Survival of Motor Neuron 1) which encodes a protein crucial for the survival and functionality of neuron cells called motor neurons. Decreased level of functioning SMN protein leads to progressive degeneration of alpha-motor neurons performing muscular motility. Over the past decade, many strategies directed for SMN-level-restoration emerged, such as gene replacement therapy (GRT), CRISPR/Cas9-based gene editing, usage of antisense oligonucleotides and small-molecule modulators, and all have been showing their perspectives in SMA therapy. In this review, modern SMA therapy strategies are described, making it a valuable resource for researchers, clinicians and everyone interested in the progress of therapy of this serious disorder.

Identifiants

pubmed: 37762045
pii: ijms241813743
doi: 10.3390/ijms241813743
pmc: PMC10530942
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Kazan Federal University
ID : FZSM-2023-0011

Références

Biochim Biophys Acta Mol Basis Dis. 2021 Apr 1;1867(4):166063
pubmed: 33412266
J Clin Neurol. 2017 Jan;13(1):27-31
pubmed: 27730768
Neuromuscul Disord. 2016 Sep;26(9):560-9
pubmed: 27460344
Int J Mol Sci. 2022 Sep 17;23(18):
pubmed: 36142791
Int J Mol Sci. 2020 May 07;21(9):
pubmed: 32392694
Neuromuscul Disord. 2018 Feb;28(2):103-115
pubmed: 29290580
Neuromuscul Disord. 2002 Feb;12(2):130-6
pubmed: 11738354
Paediatr Drugs. 2022 Nov;24(6):585-602
pubmed: 36028610
Pharmacol Ther. 2020 Mar;207:107453
pubmed: 31836454
J Cell Biol. 2003 Nov 24;163(4):801-12
pubmed: 14623865
Eur J Paediatr Neurol. 2020 Sep;28:38-43
pubmed: 32763124
Nat Biotechnol. 2009 Jan;27(1):59-65
pubmed: 19098898
J Med Chem. 2016 Nov 23;59(22):10067-10083
pubmed: 27490705
Natl Sci Rev. 2019 Sep 03;7(1):92-101
pubmed: 34691481
Nat Med. 2022 Jul;28(7):1390-1397
pubmed: 35715567
Nat Med. 2012 Feb 19;18(3):452-5
pubmed: 22344294
Sci Transl Med. 2010 Jun 9;2(35):35ra42
pubmed: 20538619
Drug Des Devel Ther. 2022 Jun 16;16:1865-1883
pubmed: 35734367
Neuromuscul Disord. 2019 Nov;29(11):842-856
pubmed: 31704158
Cureus. 2023 Mar 15;15(3):e36197
pubmed: 37065340
J Neurol. 2023 May;270(5):2531-2546
pubmed: 36735057
J Pharmacokinet Pharmacodyn. 2021 Oct;48(5):639-654
pubmed: 33991294
Genet Med. 2020 May;22(5):945-953
pubmed: 32066871
Arch Dis Child. 1973 Jun;48(6):425-30
pubmed: 4712772
Arch Neurol. 2003 Nov;60(11):1601-3
pubmed: 14623733
Nucleic Acids Res. 2023 Jul 7;51(12):5948-5980
pubmed: 37026480
Nat Commun. 2017 Nov 30;8(1):1859
pubmed: 29192144
Muscle Nerve. 2018 Jan;57(1):142-146
pubmed: 28556387
Neural Regen Res. 2019 Jun;14(6):931-938
pubmed: 30761996
Cell. 1995 Jan 13;80(1):155-65
pubmed: 7813012
N Engl J Med. 2017 Nov 2;377(18):1713-1722
pubmed: 29091557
Turk J Pediatr. 2014 Nov-Dec;56(6):643-50
pubmed: 26388596
Cochrane Database Syst Rev. 2019 Dec 11;12:CD006281
pubmed: 31825542
J Cell Biol. 1999 Nov 15;147(4):715-28
pubmed: 10562276
Brain Dev. 2017 Aug;39(7):606-612
pubmed: 28366534
Front Immunol. 2021 Mar 17;12:658399
pubmed: 33815421
Pharmaceutics. 2023 Jan 03;15(1):
pubmed: 36678797
N Engl J Med. 2017 Nov 2;377(18):1723-1732
pubmed: 29091570
Mol Ther. 2013 Feb;21(2):282-90
pubmed: 23295949
Cell Death Dis. 2019 Jul 4;10(7):515
pubmed: 31273192
Muscle Nerve. 2020 Oct;62(4):550-554
pubmed: 32710634
Lancet Neurol. 2021 Apr;20(4):284-293
pubmed: 33743238
N Engl J Med. 2021 Jul 29;385(5):427-435
pubmed: 34320287
Pediatr Pulmonol. 2019 Feb;54(2):179-185
pubmed: 30548438
J Neurol. 2002 Sep;249(9):1211-9
pubmed: 12242541
Neurology. 2019 May 21;92(21):e2492-e2506
pubmed: 31019106
Int J Mol Sci. 2022 Dec 02;23(23):
pubmed: 36499528
Hum Gene Ther. 2018 Mar;29(3):285-298
pubmed: 29378426
J Med Chem. 2018 Aug 09;61(15):6501-6517
pubmed: 30044619
Mol Ther Methods Clin Dev. 2016 Sep 14;3:16060
pubmed: 27652289
Life Sci Alliance. 2022 Apr 19;5(8):
pubmed: 35440492
Neuron. 2011 Feb 10;69(3):453-67
pubmed: 21315257
J Cell Mol Med. 2018 Feb;22(2):755-767
pubmed: 29160009
EMBO J. 1992 Dec;11(13):5071-8
pubmed: 1334463
PLoS One. 2011;6(10):e26164
pubmed: 22022549
Hum Mol Genet. 2015 Jul 15;24(14):4094-102
pubmed: 25911676
Muscle Nerve. 2021 May;63(5):668-677
pubmed: 33501671
Arch Pediatr. 2020 Dec;27(7S):7S15-7S17
pubmed: 33357591
Sci Transl Med. 2011 Mar 2;3(72):72ra18
pubmed: 21368223
Neuromuscul Disord. 2018 Mar;28(3):197-207
pubmed: 29305137
Front Cell Neurosci. 2022 Jun 16;16:826608
pubmed: 35783101
Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):E2347-E2356
pubmed: 28270613
Arch Pediatr. 2020 Dec;27(7S):7S3-7S8
pubmed: 33357595
Mol Ther. 2018 Mar 7;26(3):664-668
pubmed: 29428298
Mol Ther. 2020 Mar 4;28(3):709-722
pubmed: 31968213
Muscle Nerve. 2015 Feb;51(2):157-67
pubmed: 25346245
Cold Spring Harb Perspect Biol. 2011 Jul 01;3(7):
pubmed: 21441581
Pediatr Neurol. 2019 Sep;98:39-45
pubmed: 31277975
Lancet Neurol. 2017 Jul;16(7):513-522
pubmed: 28460889
J Med Chem. 2018 Dec 27;61(24):11021-11036
pubmed: 30407821
PLoS One. 2010 Aug 19;5(8):e12140
pubmed: 20808854
Brain Pathol. 2001 Apr;11(2):231-47
pubmed: 11303798
Brain Dev. 2014 Nov;36(10):914-20
pubmed: 24359787
Pediatrics. 2020 Sep;146(3):
pubmed: 32843442
Cell. 1998 Nov 25;95(5):615-24
pubmed: 9845364
Neuromuscul Disord. 2010 Mar;20(3):155-61
pubmed: 20074952
Front Mol Neurosci. 2015 Jul 28;8:36
pubmed: 26283910
Proc Natl Acad Sci U S A. 2018 May 15;115(20):E4604-E4612
pubmed: 29712837
J Clin Med. 2021 Nov 26;10(23):
pubmed: 34884240
Proc Natl Acad Sci U S A. 1999 May 25;96(11):6307-11
pubmed: 10339583
Eur J Hum Genet. 2012 Jan;20(1):27-32
pubmed: 21811307
Cells. 2023 Mar 01;12(5):
pubmed: 36899921
Lancet Child Adolesc Health. 2021 Jul;5(7):491-500
pubmed: 34089650
Eur J Neurol. 2023 Jul;30(7):1945-1956
pubmed: 35837793
Hum Genet. 2001 Mar;108(3):255-66
pubmed: 11354640
Muscle Nerve. 2023 May;67(5):407-411
pubmed: 36815750
Cell Rep. 2017 Dec 26;21(13):3767-3780
pubmed: 29281826
EMBO J. 1996 Jul 15;15(14):3555-65
pubmed: 8670859
Arch Neurol. 2011 Jun;68(6):779-86
pubmed: 21320981

Auteurs

Aleksei S Ponomarev (AS)

Institute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia.

Daria S Chulpanova (DS)

Institute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia.

Lina M Yanygina (LM)

Institute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia.

Valeriya V Solovyeva (VV)

Institute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia.

Albert A Rizvanov (AA)

Institute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH